Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > Are there over 200 locations on the new map?
View:
Post by Dunworkin2 on Nov 27, 2021 7:33am

Are there over 200 locations on the new map?

https://medxhealth.com/find-a-location

We exist to save lives.

Our SIAscopy on DermSecure™ is a fully integrated service that combines innovative, peer-reviewed technology with a secure, cloud-based patient management system. It’s the only tool that offers perfect image capture technology with clinical, dermascopic and spectrophotometric views of moles and other skin conditions. Designed by dermatologists and physicians, our SIAscopy on DermSecure™ is being used in over 200 pharmacies in 3 countries with regulatory approvals in 35 countries including USA, Canada, Australia, Brazil and the EU.

Comment by Insightful1 on Nov 27, 2021 10:26am
I think the difference in this statement verses the map is DermSecure is in Norway there are 104 Boots pharmacy that have the legacy standalone system in place. MedX has sold additional scopes in other countries over the years which would account for the 200 number. This uses the standalone SIAscopy technology but does not have the recurring revenue that MedX recieves off of DermSecure. So ...more  
Comment by hopefull on Nov 27, 2021 11:17am
Well I can see both sides of this. However if you look at it from the standpoint of a new investor looking at all of these 200 locations and then when the next financials come out as dismal you can understand why investors would go I don't see this as revenue producing. I think it would have been better if they would have only put pharmacies or locations that are generating revenue this is ...more  
Comment by Insightful1 on Nov 27, 2021 6:35pm
It is called "proof of concept" if MedX were raising money in the past it was able to use the 200 location and the Boots name to validate "proof of concept" in other words the SIAscope is indeed the best image capture device in the market. The issue was they have zero recurring revenue from this model as it is a one and done model. Having invested heavily in the DermSecure ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities